ArticlePharmaceuticals (Basel, Switzerland)2024

Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.

Tiffany W Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.